ArticleJournal of hepatocellular carcinoma2026

C/EBP-β Mediates the Reversal of Sorafenib Resistance by Tunicamycin in Hepatocellular Carcinoma.

Chong Pang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.